We are monitoring the impact of COVID-19 on Europe Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2702
Share on
Share on

Europe Non-Invasive Prenatal Testing Market Research Report - Segmented By Instruments, Method, Application, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) – Analysis on Market Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2702
Pages: 142

Europe Non-Invasive Prenatal Testing Market Size (2020 to 2025)

The size of the Europe Non-Invasive Prenatal Testing Market Size is valued at USD 0.52 Billion in 2020 and is projected to grow at a CAGR of 15.3%, to touch USD 1.06 Billion in 2025.

Non-invasive prenatal testing (NIPT) is a DNA test of maternal blood to detect pregnancies for the most common fetal chromosomal abnormalities, such as trisomy 21, Down syndrome, and Edwards’s trisomy 18, and Patau trisomy 13 syndromes. While NIPT can also determine the sex of the fetus, NIPT is very reliable in over 99% of Down syndrome cases. According to Eurostat, in 2019, around 47% of women in the European Union who gave birth to their first child were in the average age group of 28.4 years. Besides, in the same year, approximately 82,372 births to the first child were reported to women over 45 years of age. In England, the average age of new mothers fell from 28.6 years in 2016 to 29.4 years in 2019. In June 2020, BGI Genomics launched the NIFTY test with Eluthia, under the brand name Previa Test in Germany with a sensitivity rate greater than 99% to expand access and increase sales of non-invasive products in Germany.

The European market is driven by several factors, such as the high incidence rate of babies born with Down syndrome, the lack of risk of miscarriage with the NIPT test, the change in maternity trend to an advanced age of the mother (33 years and over), an increasing emphasis on reimbursement for NIPT and a growing preference for non-invasive techniques over invasive methods. As technology develops and the cost of genetic testing declines, researchers are hopeful that the market for non-invasive prenatal testing can be obtained for many other genetic diseases. As the non-invasive prenatal testing market is available in more and more fields, significant business momentum is expected to drive the market growth in the forecast years. Many healthcare professionals believe that the market for non-invasive prenatal testing can be implemented in routine prenatal care. Growing popularity among pregnant women as a safer alternative to amniocentesis and awareness of prenatal genetic issues drives non-invasive prenatal testing. Due to the increasing incidence of miscarriages and complications, non-invasive prenatal testing is expected to lead significant market shares.

Despite the changing trend and adoption of non-invasive prenatal testing, the market faces challenges as the government enforces strict regulations. Under these regulations, manufacturing companies must follow standardized rules to maintain test accuracy and deliver quality medical devices. Besides, these regulatory procedures are time-consuming and hamper the rapid development and innovation of devices, making it difficult for the market to grow.

This research report on the European Non-Invasive Prenatal Testing Market has been segmented and sub-segmented into the following categories:

  • By Instruments: Ultrasound, NGS, PCR, and Microarray
  • By Method: FCMB and Cf-DNA
  • By Application: Trisomy, Microdeletion, Genetics and Rh Factor
  • By End User: Hospitals and Diagnostic Labs
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Companies playing a dominant role in the Europe Non-Invasive Prenatal Testing Market profiled in this report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  2. Europe Ultrasound Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe NGS Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe PCR Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Microarray Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  7. Europe FCMB Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe cf-DNA Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  10. Europe Trisomy Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Microdeletion Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Genetics Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Rh Factor Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)
  15. Europe Hospital Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Diagnostic Labs Market, By Region, From 2020 to 2025 (USD Billion)
  17. U.K. Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  18. U.K. Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  19. U.K. Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  20. U.K. Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)
  21. Germany Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  22. Germany Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  23. Germany Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  24. Germany Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)
  25. France Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  26. France Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  27. France Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  28. France Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)
  29. Italy Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  30. Italy Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  31. Italy Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  32. Italy Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)
  33. Spain Non-Invasive Prenatal Testing Market, By Instruments, From 2020 to 2025 (USD Billion)
  34. Spain Non-Invasive Prenatal Testing Market, By Method, From 2020 to 2025 (USD Billion)
  35. Spain Non-Invasive Prenatal Testing Market, By Application, From 2020 to 2025 (USD Billion)
  36. Spain Non-Invasive Prenatal Testing Market, By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample